Tag: C2N Diagnostics

All

C2N Diagnostics’ eMTBR-tau243 Plasma Assay Used in Alzheimer’s Phase 3 Trial Dataset

The biomarker showed independent associations with cognitive and functional decline, offering complementary information alongside p-tau217 in early symptomatic Alzheimer's disease.

C2N Diagnostics Triples St. Louis Operations with New 82,000-Square-Foot Facility
C2N Diagnostics Lowers Age Limit for Alzheimer’s Blood Test to 50
Alzheimer’s Disease Blood Biomarker Test Improves Clinical Decision-Making
Alzheimer’s Drug Discovery Foundation Invests $7 Million in Blood Tests
C2N’s Precivity Tests Now Offered Through Mayo Clinic Labs
This Blood Test Could Provide Significant Cost Savings in Alzheimer’s Diagnosis
Alzheimer’s Blood Test Identifies Cognitive Impairment with High Accuracy
Blood Biomarkers in C2N Test Accurately Evaluate Brain Amyloid in Preclinical Alzheimer’s
Robust Blood Test for Alzheimer’s Released

All

How C2N Diagnostics’ Blood Test Helps Affirm Alzheimer’s Diagnosis

C2N Diagnostics says new research affirms the clinical utility of its PrecivityAD blood test to help diagnose Alzheimer’s.

C2N Diagnostics’ Precivity-Related Blood Biomarkers Improve Alzheimer’s Diagnostic Accuracy
Researchers to Aim to Use New Blood Test to Prevent Memory Loss

Tag: C2N Diagnostics

All

C2N Diagnostics’ eMTBR-tau243 Plasma Assay Used in Alzheimer’s Phase 3 Trial Dataset

C2N Diagnostics Triples St. Louis Operations with New 82,000-Square-Foot Facility

C2N Diagnostics Lowers Age Limit for Alzheimer’s Blood Test to 50

Alzheimer’s Disease Blood Biomarker Test Improves Clinical Decision-Making

Alzheimer’s Drug Discovery Foundation Invests $7 Million in Blood Tests

C2N’s Precivity Tests Now Offered Through Mayo Clinic Labs

This Blood Test Could Provide Significant Cost Savings in Alzheimer’s Diagnosis

Alzheimer’s Blood Test Identifies Cognitive Impairment with High Accuracy

Blood Biomarkers in C2N Test Accurately Evaluate Brain Amyloid in Preclinical Alzheimer’s

Robust Blood Test for Alzheimer’s Released

All

How C2N Diagnostics’ Blood Test Helps Affirm Alzheimer’s Diagnosis

C2N Diagnostics’ Precivity-Related Blood Biomarkers Improve Alzheimer’s Diagnostic Accuracy

Researchers to Aim to Use New Blood Test to Prevent Memory Loss

All

Sorry, No Posts Found

Sorry, No Posts Found

Clinical Lab Products

Our Parent Company

Key Resources

Helpful Links